The 20 Best Hereditary Neuroblastoma Doctors in New York, US

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Anal Cancer, Laryngeal Cancer, Throat Cancer, and Cervical Cancer.

Keyur Mehta is a Radiation Oncologist in Bronx, New York. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Breast Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

Justin Tang is a Radiation Oncologist in Bronx, New York. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Fibrolamellar Carcinoma, Familial Prostate Cancer, Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Jana Fox is a Radiation Oncologist in Bronx, New York. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Laryngeal Cancer, and Throat Cancer.

Antonio Fojo is an Internal Medicine provider in New York, New York. Dr. Fojo is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Neuroendocrine Tumor, Pheochromocytoma, Adrenal Cancer, and Adrenocortical Carcinoma. Dr. Fojo is currently accepting new patients.

Zoltan Antal is a Pediatric Endocrinologist in New York, New York. Dr. Antal is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Hereditary Neuroblastoma, Neurohypophyseal Diabetes Insipidus, Diabetes Insipidus (DI), and Malnutrition.

Julie Krystal is a Pediatrics specialist and an Oncologist in New Hyde Park, New York. Dr. Krystal is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Neuroblastoma, Medulloblastoma, Acute Lymphoblastic Leukemia (ALL), Rhabdomyosarcoma, and Bone Marrow Aspiration.

Thomas Bradley, MD, FACP, is Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As System Head for Genitourinary Cancers for the Northwell Health Cancer Institute, Dr. Bradley has special expertise in the management of prostate, kidney, bladder, and testicular cancers. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Bradley maintains an active practice where he focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. Dr. Bradley has a keen interest in the education of future physicians as evidenced by his directorship of the Fellowship program in Hematology and Medical Oncology for many years. His research work as principal investigator for numerous drug trials and multiple collaborations has resulted in dozens of publications and abstracts. Dr. Bradley earned his medical degree from the University of Monterrey School of Medicine. He trained in internal medicine as well as hematology and medical oncology at the State University of New York at Downstate Medical Center. Dr. Bradley is an active member of the American Society of Hematology, American Society of Clinical Oncology, American Association for Cancer Research and the American College of Physicians. Dr. Bradley is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Bone Marrow Aspiration.

Bahar Laderian, MD, is Director of the Neuroendocrine Tumors Program at Montefiore Einstein Comprehensive Cancer Center and Assistant Professor of Medicine and Oncology at Albert Einstein College of Medicine. Dr. Laderian’s clinical focus is on the treatment of neuroendocrine tumors (carcinoid), adrenocortical carcinoma and carcinomas, pheochromocytomas, paragangliomas, and gastrointestinal cancers including anal cancers, colorectal cancers, cancer of the appendix, intestinal cancers, anal cancers, pancreatic cancers, hepatocellular carcinomas, cholangiocarcinomas and gastroesophageal cancers. Dr. Laderian is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Glomus Tympanum Tumor, Glomus Jugulare Tumor, Lynch Syndrome, Gastroesophageal Junction Cancer, and Gamma Knife Radiosurgery.

Brenton Francisco is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Francisco is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Sickle Cell Disease, Hemophilia A, Hemophilic Arthropathy, and Hemoglobin SC Disease.

Mark Atlas is a Pediatric Hematologist Oncology provider in Lake Success, New York. Dr. Atlas is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Optic Glioma, Glioma, Medulloblastoma, and Acute Lymphoblastic Leukemia (ALL).

Carolyn Levy is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Langerhans Cell Histiocytosis, Acute Lymphoblastic Leukemia (ALL), Hemi 3 Syndrome, Cantu Syndrome, and Bone Marrow Aspiration.

Arlene Redner is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Optic Glioma, Acute Lymphoblastic Leukemia (ALL), Classical Hodgkin Lymphoma, and Febrile Neutropenia.

Rachel Kessel is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Kessel is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Congenital Athymia, Sickle Cell Disease, and Acute Megakaryoblastic Leukemia.

Lawrence Wolfe is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Wolfe is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Thalassemia, Beta Thalassemia, Hereditary Spherocytosis, and Hemolytic Anemia.

Anshul Vagrecha is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Vagrecha is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Multisystem Inflammatory Syndrome in Children (MIS-C), Sickle Cell Disease, and Febrile Neutropenia.

Banu Aygun is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Aygun is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.